High-risk groups to be inoculated nationwide By ZHANG ZHIHAO | China Daily | Updated: 2020-12-21 09:13 Share CLOSE A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]
China will focus on nationwide vaccination of people and workers deemed at high risk of contracting COVID-19 over the winter and spring, as the cold weather can complicate prevention and control efforts, senior health officials said.
The high-risk groups include workers in customs, medicine and healthcare, the cold chain industry, public transportation, produce and seafood markets, and those traveling to medium－or high-risk areas for work or study, said Cui Gang, a senior official of the National Health Commission s Bureau of Disease Prevention and Control.
High-risk groups to be inoculated nationwide- China org cn china.org.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from china.org.cn Daily Mail and Mail on Sunday newspapers.
Minister: Sinopharm may resume trial in Peru China Daily Global | Updated: 2020-12-20 11:53 A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co., Ltd. (Sinopharm) in Beijing, April 10, 2020.
LIMA－The Peruvian health minister said that China s Sinopharm could resume a trial for its coronavirus vaccine in the hard-hit Andean nation, just days after authorities suspended the tests to better understand why a volunteer had fallen ill.
Health authorities announced over last weekend that the Sinopharm trial would be temporarily halted as a safety measure after a volunteer experienced decreased strength in his legs, among other symptoms.
REUTERS
THE DEPARTMENT of Health (DoH) reported 1,156 coronavirus infections on Wednesday, bringing the total to 452,988.
The death toll reached 8,833 after 21 more patients died, while recoveries increased by 425 to 419,282, it said in a bulletin.
There were 24,873 active cases, 84.7% of which were mild, 6.7% did not show symptoms, 5.6% were critical, 2.8% were severe and 0.3% were moderate.
Davao City reported the highest number of cases at 126, followed by Quezon City at 66, Rizal at 64, Bulacan at 56 and Manila at 38.
DoH said seven duplicates had been removed from the tally, while seven recovered cases were reclassified as deaths. Five laboratories failed to submit their data on Dec. 15, it added.
Government to pay 200 yuan per dose of Chinese COVID-19 inactivated vaccines Source: Global Times Published: 2020/12/16 14:14:30
A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co., Ltd. (Sinopharm) in Beijing, capital of China, April 10, 2020. (Xinhua/Zhang Yuwei)
Leading Chinese COVID-19 vaccine producers including Sinopharm and Sinovac will charge the government 200 yuan ($30.57) per dose, as East China s Jiangsu becomes the latest province to purchase two types of domestically developed inactivated vaccines for emergency use at this wholesale price, according to a public document posted on the official website on Tuesday.